UPDATE 1-Shanghai Pharma bids for U.S. Cardinal Health’s China business

* Shanghai Pharma makes two non-binding bids for Cardinal China * Cardinal China had revenue of more than $3.5 bln last year (Adds Lazard declined comment) By Julie Zhu HONG KONG, Oct 18 (Reuters) – Shanghai Pharmaceuticals Holding Co has bid for Cardinal …
( read original story …)



Related Post